Schedule 13G ownership disclosure

BIODESIX INC

Common Stock, par value $0.001 per share · CUSIP: 09075X207

Event date: 2026-01-12

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Soleus Capital Master Fund, L.P.

    Shares: 500,000.00 · Class: 6.3%

  • Soleus Capital, LLC

    Shares: 500,000.00 · Class: 6.3%

  • Soleus Capital Group, LLC

    Shares: 500,000.00 · Class: 6.3%

  • Soleus Capital Management, L.P.

    Shares: 500,000.00 · Class: 6.3%

  • Soleus GP, LLC

    Shares: 500,000.00 · Class: 6.3%

  • Guy Levy

    Shares: 500,000.00 · Class: 6.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-26-003938
Form type
SCHEDULE 13G
Filer
BIODESIX INC
CIK
CIK 1439725
Filed
Jan 13, 2026
Reporting period
Jan 12, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub